- Home
- DBI vs VYGR Comparison
DBI vs VYGR Comparison
Compare DBI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- VYGR
- Stock Information
- Founded
- DBI 1991
- VYGR 2013
- Country
- DBI United States
- VYGR United States
- Employees
- DBI N/A
- VYGR N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- VYGR Health Care
- Exchange
- DBI Nasdaq
- VYGR Nasdaq
- Market Cap
- DBI 292.2M
- VYGR 309.7M
- IPO Year
- DBI 1991
- VYGR 2015
- Fundamental
- Price
- DBI $5.80
- VYGR $6.24
- Analyst Decision
- DBI Hold
- VYGR Strong Buy
- Analyst Count
- DBI 3
- VYGR 9
- Target Price
- DBI $6.50
- VYGR $16.44
- AVG Volume (30 Days)
- DBI 1.9M
- VYGR 574.8K
- Earning Date
- DBI 12-10-2024
- VYGR 11-12-2024
- Dividend Yield
- DBI 3.49%
- VYGR N/A
- EPS Growth
- DBI N/A
- VYGR N/A
- EPS
- DBI N/A
- VYGR 0.47
- Revenue
- DBI $3,059,173,000.00
- VYGR $163,784,000.00
- Revenue This Year
- DBI $0.78
- VYGR N/A
- Revenue Next Year
- DBI $3.19
- VYGR N/A
- P/E Ratio
- DBI N/A
- VYGR $13.43
- Revenue Growth
- DBI N/A
- VYGR 3.40
- 52 Week Low
- DBI $4.36
- VYGR $5.19
- 52 Week High
- DBI $11.57
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- DBI 56.43
- VYGR 48.71
- Support Level
- DBI $4.76
- VYGR $5.54
- Resistance Level
- DBI $5.69
- VYGR $7.44
- Average True Range (ATR)
- DBI 0.41
- VYGR 0.36
- MACD
- DBI 0.16
- VYGR 0.09
- Stochastic Oscillator
- DBI 71.35
- VYGR 46.67
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.